Shanghai, China · Founded 2018 · Privately Held (backing)
Developer of recombinant protein drug intended for synthetic biology. Ruoyi Bio is based in Shanghai, China and was founded in 2018. Its last reported valuation was $23.4 million in Mar 2022. It has raised $7.6 million.
Last reported valuation
$23.4M
Oct 2026
Priced at
—
Total raised
$7.6M
Last round
—
Team — not yet on record
No current team members for Ruoyi Bio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ruoyi Bio with a free account
·Watch Ruoyi Bio: the Monday email on marks, rounds and moves
